Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

[Rexetin in the therapy of depressive states]

[Rexetin in the therapy of depressive states] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • [Rexetin in the therapy of depressive states] Abstract Text:

    a s bobrovA S Bobrov,o v petrun'koO V Petrun'ko,a v kovalevaA V Kovaleva,o n pavlovaO N Pavlova,

    Rexetin was used in the dosage of 20-60 mg daily during 6 weeks in the treatment of 25 patients with depression. An efficacy of the therapy was evaluated by the Hamilton scales for Depression (HAM-D) and anxiety (HAM-A) and Montgomery-Asberg Scale (MADRS). Patients were considered as responders if they demonstrated the reduction of scores by 50%. Twenty-three responders (92.0%) were divided into 3 groups: the first--with immediate therapeutic response during 1-2 weeks (n = 8; 34.8%); the second--with positive dynamics at the 3rd week of the treatment (n = 9; 39.1%); the third group--with favorable results at the end of 5-6 week of the therapy (n = 6; 26.1%). The clinical predictors of different therapeutic responses during short-term therapy were as follows: severity of depressive episode, hypotimia of modality (anxiety, anxiety-sorrow); vitalization of verbal/ nonverbal sorrow affect; presentation of autonomic (somatic) appearances of generalized anxiety disorder; ranks of typical depressive symptoms in subjective perception of patients; character of sleep disorders, presence of atypical depressive symptoms, in particular a disturbance of interpersonal relations due to elevated irritability; localization and extent of generalization of pathological body sensations; dominant content of obsessive anxiety; a type of affective triad; panic attacks, with- or without agoraphobia, concomitant to depressive disorder. In the total group of responders, there was a simultant (harmonic) reduction of the total score on the depression and anxiety scales (65.2%) and the anticipating anxiolytic or thymoanaleptic effect of the drug was observed less often (34.8%).

    [Rexetin in the therapy of depressive states] Publishing Authors By Initials

    as bobrovAS Bobrov,ov petrun'koOV Petrun'ko,av kovalevaAV Kovaleva,on pavlovaON Pavlova,

    For similar diagnosis: prognosis: treatment outcome research abstracts see: diagnosis: prognosis: treatment outcome research

    PUBMED ID PMID:

    MEDLINE DATE:

    [Rexetin in the therapy of depressive states] Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsak

    VOLUME: 105

    Page Numbers: 30-4

    Journal Abbreviation:

    ISSN: 1997-7298

    DAY: 31

    MONTH: 03

    YEAR: 2005

    [Rexetin in the therapy of depressive states] Information

    Number of References:

    LANGUAGE: rus

    NlmUniqueID: 9712194

    [Rexetin in the therapy of depressive states] Keywords Mesh Terms:

    KEYWORDS: Treatment Outcome

    MESH TERMS: therapeutic use

    Chemical & Substance for Abstract: [Rexetin in the therapy of depressive states] Information

    Substance Name: Paroxetine

    Registry Number: 61869-08-7

    Grant and Affiliation Information for [Rexetin in the therapy of depressive states]

    AFFILIATION:

    Country: Russia (Federation)

    Russia (Federation) Research PublicationRussia (Federation) Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Zh Nevrol Psikhiatr Im S S Kor

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Rexetin in the therapy of depressive states Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News